Protease-activated receptor-2 (PAR-2) is a
G protein-coupled receptor activated by
trypsin and other
trypsin-like
serine proteases. The widely expressed PAR-2 is involved in
inflammation response but the physiological/pathological roles of PAR-2 in the nervous system are still uncertain. In the present study, we report novel PAR-2 interaction
proteins, alphaA-
crystallin and alphaB-
crystallin. These 20 kDa
proteins have been implicated in
neurodegenerative diseases like
Alexander's disease,
Creutzfeldt-Jacob disease,
Alzheimer's disease, and
Parkinson's disease. Results from yeast two-hybrid assay using the cytoplasmic C-tail of PAR-2 as bait suggested that alphaA-
crystallin interacts with PAR-2. We further demonstrate the in vitro and cellular in vivo interaction of C-tail of PAR-2 as well as of full-length PAR-2 with alphaA(alphaB)-
crystallins. We use pull-down, co-immunoprecipitation, and co-localization assays. Analysis of alphaA-
crystallin deletion mutants showed that
amino acids 120-130 and 136-154 of alphaA-
crystallin are required for the interaction with PAR-2. Co-immunoprecipitation experiments ruled out an interaction of alphaA(alphaB)-
crystallins with PAR-1, PAR-3, and PAR-4. This demonstrates that alphaA(alphaB)-
crystallins are PAR-2-specific interaction
proteins. Moreover, we investigated the functional role of PAR-2 and
alpha-crystallins in astrocytes. Evidence is presented to show that PAR-2 activation and increased expression of
alpha-crystallins reduced C2-ceramide- and
staurosporine-induced cell death in astrocytes. Thus, both PAR-2 and
alpha-crystallins are involved in cytoprotection in astrocytes.